✦ LIBER ✦

1180 ALT flares in patients with HBEAG-positive chronic hepatitis B and treated with either conventional interferon alfa-2A or peginterferon alfa-2A (40KD) (PEGASYS®) are not necessary for a significant response to therapy

✍ Scribed by GRAHAM, W; COOKSLEY, E; LAI, M; PIRATVISUTH, T; WANG, Y; MAHACHAI, V; CHAO, Y; TANWANDEE, T; CHUTAPUTTI, A; CHANG, W

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with peginterferon alfa-2a (40

✍ W.G.E. Cooksley; M.-Y. Lai; T. Piratvisuth; Y.-J. Wang; V. Mahachai; Y.-C. Chao; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 135 KB

103 VIROLOGICAL AND BIOCHEMICAL RESPONSE

✍ P. Marcellin; T. Piratvisuth; M. Brunetto; F. Bonino; G.K.K. Lau; P. Farci; C. Y 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 63 KB

421 A new bio-mathematical model to desc

✍ P. Colombatto; R. Bizzarri; L. Civitano; F. Oliveri; F. Bonino; G. Germanidis; P 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 64 KB